By Counterforce Health Team in Symdeko / Symkevi (tezacaftor/ivacaftor) —

Getting Symdeko/Symkevi (Tezacaftor/Ivacaftor) Covered by Cigna in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Your Fastest Path to Coverage

To get Symdeko/Symkevi covered by Cigna in Virginia: Submit prior authorization through your CF specialist with complete genotype documentation (including F508del mutation proof), recent pulmonary function tests, and treatment history. Most approvals come within 5 business days when documentation is complete. If denied, file internal appeal within 180 days, then external review through Virginia's Bureau of Insurance within 120 days. Start today: Call your CF specialist to request PA submission through Cigna's EviCore portal or Accredo specialty pharmacy at 1-800-803-2523.

Table of Contents

  1. Cigna Plan Types & Coverage Differences
  2. Symdeko/Symkevi Formulary Status
  3. Prior Authorization Requirements
  4. Specialty Pharmacy Setup
  5. Cost-Share Basics
  6. Submission Process
  7. Common Approval Patterns
  8. Appeals Process in Virginia
  9. FAQ
  10. Resources & Next Steps

Cigna Plan Types & Coverage Differences

Your Cigna plan type significantly impacts how you access Symdeko/Symkevi coverage in Virginia:

Plan Type Referral for CF Specialist Network Restrictions Key Considerations
HMO May be required* In-network only Check if PCP referral needed
PPO Not required In/out-of-network options Higher out-of-network costs
EPO Not required In-network only (except emergencies) No out-of-network coverage

*Virginia law exempts specialists treating degenerative conditions like cystic fibrosis from referral requirements in many cases. Contact Cigna at 1-866-494-2111 to confirm your specific plan's rules.

Symdeko/Symkevi Formulary Status

Symdeko/Symkevi typically appears on Tier 4 or 5 of Cigna formularies as a specialty medication with the following restrictions:

  • Prior Authorization (PA): Required before coverage
  • Specialty Pharmacy: Must be dispensed through Accredo or approved specialty pharmacy
  • Quantity Limits: Based on FDA-approved dosing (typically 28-day supply)

The medication is not explicitly listed in standard 2024-2025 Cigna formularies, but CFTR modulators for cystic fibrosis consistently fall into high-tier specialty categories with comprehensive utilization management.

Step Therapy Considerations

While step therapy may apply, patients with F508del mutations often qualify for direct approval when:

  • Previous CFTR modulator use is documented
  • Treatment failures or intolerances are recorded
  • Clinical necessity is demonstrated through PFTs and specialist notes

Prior Authorization Requirements

Cigna requires comprehensive documentation for Symdeko/Symkevi approval:

Essential Documentation Checklist

✅ Confirmed CF diagnosis with ICD-10 codes
✅ CFTR genotype report showing F508del or responsive mutation
✅ Prescription from CF specialist (pulmonologist or CF center physician)
✅ Recent pulmonary function tests (within 90 days)
✅ Baseline laboratory values (AST/ALT/bilirubin within 90 days)
✅ Prior treatment history including other CFTR modulators tried/failed
✅ Medical necessity letter explaining clinical rationale

Genotype Requirements

Symdeko/Symkevi is approved for patients age 6 and older with:

  • One F508del mutation and one mutation with residual function
  • Specific responsive mutations as listed in FDA labeling

Your genetic testing must be performed by an FDA-cleared laboratory with results clearly documenting eligible mutations.

Specialty Pharmacy Setup

Cigna partners with Accredo for CFTR modulator dispensing. Here's the setup process:

  1. Enrollment: Your prescriber or you can call Accredo at 1-800-803-2523
  2. Insurance verification: Accredo confirms Cigna coverage and PA status
  3. Delivery setup: Choose home delivery or clinic administration
  4. Ongoing support: Accredo provides refill reminders and clinical monitoring
Tip: Accredo operates Monday-Friday 7am-10pm CST, Saturday 7am-4pm CST. They assist with both PA submissions and status tracking.

Cost-Share Basics

Symdeko/Symkevi's annual list price approaches $323,491, making cost-sharing a significant consideration:

  • Tier 4/5 specialty drugs typically require 25-40% coinsurance after deductible
  • Deductible: Must be met before coinsurance applies (varies by plan)
  • Out-of-pocket maximum: Annual limit on your total costs

Cost Assistance Options

  • Vertex Pathways Patient Support Program: May reduce copays for eligible patients
  • Virginia pharmaceutical assistance programs: Limited availability for high-cost specialty drugs
  • Cigna formulary exceptions: Request lower-tier placement if alternatives are ineffective

Submission Process

For Healthcare Providers

Fastest submission methods:

  1. EviCore by Evernorth portal: Select "Pharmacy Drugs (Express Scripts Coverage)"
  2. CoverMyMeds platform: 70% time savings, 35% faster than phone/fax
  3. MyAccredoPatients.com: Direct submission with specialty pharmacy integration

Phone/Fax backup:

  • Phone: 1-800-882-4462
  • Mail: Cigna Attn. Precertification and Referral Department, 1640 Dallas Parkway, Plano, TX 75093

For Patients

Track your PA status:

  • myCigna portal: my.cigna.com for real-time updates
  • PromptPA portal: cigna.promptpa.com/viewrequeststatus.aspx
  • Accredo patient portal: Direct specialty pharmacy communication

Common Approval Patterns

Successful Symdeko/Symkevi approvals typically include:

Strong Medical Necessity Letters Address:

  • Clinical problem: Current CF symptoms and disease progression
  • Prior treatments: Other CFTR modulators tried, outcomes, and reasons for discontinuation
  • Specific rationale: Why Symdeko/Symkevi is medically necessary for this patient
  • Guideline support: References to CF Foundation guidelines or FDA labeling
  • Monitoring plan: How treatment response will be assessed

Common Denial Reasons & Solutions

Denial Reason Solution Required Documentation
Missing genotype Submit genetic testing results FDA-cleared lab report showing F508del
Incomplete clinical information Provide comprehensive history PFTs, specialist notes, treatment timeline
Prescriber qualifications Verify specialist credentials CF center affiliation or pulmonology certification
Missing baseline labs Include recent laboratory values AST/ALT/bilirubin within 90 days

Appeals Process in Virginia

If your initial PA is denied, Virginia provides robust appeal rights:

Internal Appeals (Cigna)

  • Timeline: File within 180 days of denial
  • Method: myCigna portal, phone (1-800-244-6224), or written request
  • Required documents: Denial letter, updated medical necessity letter, supporting evidence
  • Decision timeframe: Standard appeals decided within 30 days; expedited within 72 hours for urgent cases

External Review (Virginia Bureau of Insurance)

After completing internal appeals, you have additional rights:

  • Timeline: 120 days from final internal denial to request external review
  • Cost: Free (no filing fee)
  • Process: Independent medical review by board-certified physicians
  • Decision timeframes:
    • Standard: 45 days
    • Expedited: 72 hours (urgent cases)
    • Ultra-expedited: 24 hours (life-threatening situations)

Contact Virginia Bureau of Insurance:

  • Phone: 1-877-310-6560
  • Website: scc.virginia.gov (search "External Review")
  • Forms: Form 216-A (External Review Request)
From our advocates: We've seen CF patients succeed in external review when they include peer-reviewed studies showing Symdeko/Symkevi's efficacy for their specific genotype, along with detailed documentation of treatment failures with alternative CFTR modulators. The key is demonstrating that this specific medication addresses their particular genetic variant and clinical needs.

When to Contact Virginia's Managed Care Ombudsman

For complex coverage issues or plan disputes, Virginia's Office of the Managed Care Ombudsman provides free assistance:

  • Same phone number: 1-877-310-6560
  • Helps resolve issues informally before formal appeals
  • Particularly valuable for HMO and managed care plan disputes

Clinician Corner: Medical Necessity Letter Essentials

Key elements for approval:

✅ Patient identification: Age, weight, CF genotype
✅ Diagnosis confirmation: ICD-10 codes, genetic testing results
✅ Treatment history: Prior CFTR modulators, outcomes, adverse effects
✅ Clinical rationale: Why Symdeko/Symkevi is appropriate for this genotype
✅ Guideline references: CF Foundation guidelines, FDA labeling
✅ Monitoring plan: PFT schedule, laboratory monitoring, clinic visits
✅ Contraindications addressed: Why alternatives are unsuitable

Helpful references:

FAQ

How long does Cigna prior authorization take for Symdeko/Symkevi in Virginia? Most PAs are processed within 5 business days when complete documentation is submitted. Expedited reviews for urgent cases are available within 24-48 hours.

What if Symdeko/Symkevi is not on my Cigna formulary? Request a formulary exception through your prescriber. Include medical necessity documentation and evidence that formulary alternatives are inappropriate for your genotype.

Can I get expedited appeals in Virginia? Yes. Virginia allows expedited external review within 72 hours if your physician certifies that waiting could seriously jeopardize your health.

Does step therapy apply if I haven't tried other CFTR modulators? It depends on your specific genotype and clinical history. F508del patients often qualify for direct approval, especially with documented contraindications to alternatives.

What happens if my appeal is denied? After exhausting internal and external appeals, you may have legal options. Consider consulting with a healthcare attorney or patient advocacy organization.

Are there cost assistance programs for Symdeko/Symkevi? Yes. Vertex offers the Pathways Patient Support Program, and various foundations provide grants for CF medications. Your CF care team can help identify options.

Resources & Next Steps

Immediate Action Steps

  1. Contact your CF specialist to initiate PA submission
  2. Gather required documentation using the checklist above
  3. Set up Accredo specialty pharmacy account
  4. Monitor PA status through myCigna or PromptPA portals

Key Contacts

  • Cigna Customer Service: 1-866-494-2111
  • Accredo Specialty Pharmacy: 1-800-803-2523
  • Virginia Bureau of Insurance: 1-877-310-6560
  • Vertex Patient Support: 1-877-752-5933

Official Resources

Getting specialized help: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Their platform identifies denial reasons and drafts point-by-point rebuttals aligned to your plan's specific rules, pulling the right medical citations and clinical evidence for CFTR modulators like Symdeko/Symkevi.

If you're facing a complex denial or need assistance navigating Cigna's requirements in Virginia, professional advocacy can significantly improve your chances of approval while reducing the administrative burden on your care team.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage varies by individual plan. Always consult with your healthcare provider and insurance company for personalized guidance. For official Virginia insurance regulations and appeal procedures, contact the Virginia Bureau of Insurance directly.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.